Breakthrough bacteraemia due to tigecycline-resistant escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 11, 2011, Pages 2677-2678

  Stone, Neil R H ^a   Woodford, Neil ^b   Livermore, David M ^b   Howard, Julia ^a   Pike, Rachel ^b   Mushtaq, Shazad ^b   Perry, Claire ^b   Hopkins, Susan ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Carbapenemases; Emerging infections; Glycylcycline resistance

Indexed keywords

CIPROFLOXACIN; COLISTIN; FLUCLOXACILLIN; MEROPENEM; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TIGECYCLINE; UNCLASSIFIED DRUG;

ADULT; AGAR DILUTION; BACTEREMIA; BACTERIUM ISOLATE; CALCINOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPSILOMETER TEST; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES CULTURE; GRAND MAL SEIZURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; LOADING DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NEUROTOXICITY; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SKIN ULCER;

BACTEREMIA; BETA-LACTAMASES; CALCIPHYLAXIS; COINFECTION; COLISTIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MIDDLE AGED; MINOCYCLINE;

EID: 80054682045     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr337     Document Type: Letter

References (6)

1. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53: 5046-54.
2. Moellering RC. NDM-1 - a cause for worldwide concern. N Engl J Med 2010; 363: 2377-9.
3. Brandenburg VM, Cozzolino M, Ketteler M. Calciphylaxis: a still unmet challenge. J Nephrol 2011; 24: 142-8.
4. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006; 10: R27.
5. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
6. Livermore DM, Warner M, Mushtaq S et al. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011; 37: 415-9.